Effects of an extended therapeutic strategy versus standard-of-care therapy on persistent acute kidney injury in high-risk patients after major surgery: study protocol for the randomised controlled single-centre PrevProgAKI trial
Authors
Hendrik Booke (ORCID: https://orcid.org/0000-0002-0227-7367)
Thilo von Groote
Joachim Gerß (ORCID: https://orcid.org/0000-0003-3489-683X)
Alexander Zarbock (ORCID: https://orcid.org/0000-0002-2124-1714)
John A. Kellum (ORCID: https://orcid.org/0000-0003-1995-2653)
Effects of an extended therapeutic strategy versus standard-of-care therapy on persistent acute kidney injury in high-risk patients after major surgery: study protocol for the randomised controlled single-centre PrevProgAKI trial
Hendrik Booke, Thilo von Groote, Joachim Gerß, Alexander Zarbock et al.
Citations
4 citations
Journal
BMJ Open
Topics
Acute Kidney Injury Research
Field-Weighted Citation Impact (FWCI)
5.72
article
Effects of an extended therapeutic strategy versus standard-of-care therapy on persistent acute kidney injury in high-risk patients after major surgery: study protocol for the randomised controlled single-centre PrevProgAKI trial
Hendrik Booke, Thilo von Groote, Joachim Gerß, Alexander Zarbock, John A. Kellum, Leonie Sauermann, Mahan Sadjadi, Melanie Meersch, Christian Strauß, Carola Wempe, Ludwig Maximilian Schöne
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(5)
Institutions
University of Pittsburgh (US), University of Münster (DE), University Hospital Münster (DE)